Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients

Author(s): Fan Y | Huang Z | Fang L | Miu L | Lin N | Gong L | Yu H | Yang H | Mao W
Volume: 2013
Issue: default
Year: 2013

Optical imaging of head and neck squamous cell carcinoma in vivo using arginine-glycine- aspartic acid peptide conjugated near-infrared quantum dots

Author(s): Huang H | Bai YL | Yang K | Tang H | Wang YW
Volume: 2013
Issue: default
Year: 2013

Sam68 is a novel marker for aggressive neuroblastoma

Author(s): Zhao X | Li Z | He B | Liu J | Li S | Zhou L | Pan C | Yu Z | Xu Z
Volume: 2013
Issue: default
Year: 2013

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Author(s): Rossi L | Veltri E | Zullo A | Zoratto F | Colonna M | Longo F | Mottolese M | Giannarelli D | Ruco L | Marchetti P | Romiti A | Barucca V | Giannini G | Bianchi L | Tomao S
Volume: 2013
Issue: default
Year: 2013

Signal transduction molecule patterns indicating potential glioblastoma therapy approaches

Author(s): Cruceru ML | Enciu AM | Popa AC | Albulescu R | Neagu M | Tanase CP | Constantinescu SN
Volume: 2013
Issue: default
Year: 2013

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials

Author(s): Zhang Y | Sun Y | Wang L | Ye T | Pan Y | Hu H | Yu Y | Zhao N | Song Y | Garfield D | Chen H
Volume: 2013
Issue: default
Year: 2013

Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity

Author(s): Gadiot J | Hooijkaas AI | Deken MA | Blank CU
Volume: 2013
Issue: default
Year: 2013

Niclosamide suppresses hepatoma cell proliferation via the Wnt pathway

Author(s): Tomizawa M | Shinozaki F | Motoyoshi Y | Sugiyama T | Yamamoto S | Sueishi M | Yoshida T
Volume: 2013
Issue: default
Year: 2013

Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis

Author(s): Cheng Q | Yi B | Wang A | Jiang X
Volume: 2013
Issue: default
Year: 2013

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma

Author(s): Qin XJ | Zhang HL | Ye DW | Dai B | Zhu Y | Shi GH
Volume: 2013
Issue: default
Year: 2013

Profile of panobinostat and its potential for treatment in solid tumors: an update

Author(s): Anne M | Sammartino D | Barginear MF | Budman D
Volume: 2013
Issue: default
Year: 2013

The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells

Author(s): Chai F | Zhou J | Chen C | Xie S | Chen X | Su P | Shi J
Volume: 2013
Issue: default
Year: 2013

Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer

Author(s): Kim JS | Lee SD | Lee SJ | Chung MK
Volume: 2013
Issue: default
Year: 2013

Prognostic factors associated with solitary plasmacytoma

Author(s): Guo SQ | Zhang L | Wang YF | Sun BC | Zhang LY | Zhang J | Wang GW | Zhang YZ
Volume: 2013
Issue: default
Year: 2013

Pulmonary adenocarcinoma with osseous metaplasia: a rare occurrence possibly associated with early stage?

Author(s): Zhang Q | Yin L | Li B | Meng R | Dao R | Hu S | Qiu X
Volume: 2013
Issue: default
Year: 2013

Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma

Author(s): Peng HH | Zhang YD | Gong LS | Liu WD | Zhang Y
Volume: 2013
Issue: default
Year: 2013

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification

Author(s): Shimada Y | Saji H | Nomura M | Matsubayashi J | Yoshida K | Kakihana M | Kajiwara N | Ohira T | Ikeda N
Volume: 2013
Issue: default
Year: 2013

Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature

Author(s): Lin Y | Li Q | Huang W | Jia X | Jiang H | Gao Y | Li Q
Volume: 2013
Issue: default
Year: 2013

Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma

Author(s): Feng JF | Huang Y | Liu JS
Volume: 2013
Issue: default
Year: 2013

Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial

Author(s): Liang J | E M | Wu G | Zhao L | Li X | Xiu X | Li N | Chen B | Hui Z | Lv J | Fang H | Tang Y | Bi N | Wang W | Zhai Y | Li T | Chen D | Zou SM | Lu N | Perez-Rodríguez R | Zheng J | Wang L
Volume: 2013
Issue: default
Year: 2013

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Author(s): Mai CW | Kang YB | Pichika MR
Volume: 2013
Issue: default
Year: 2013

Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells

Author(s): Fang ZT | Wang GZ | Zhang W | Qu XD | Liu R | Qian S | Zhu L | Zhou B | Wang JH
Volume: 2013
Issue: default
Year: 2013

Diagnostic efficacy of computed tomography-guided transthoracic needle aspiration and biopsy in patients with pulmonary disease

Author(s): Tuna T | Ozkaya S | Dirican A | Findik S | Atici AG | Erkan L
Volume: 2013
Issue: default
Year: 2013

Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients

Author(s): He L | Peng K | Liu Y | Xiong J | Zhu FF
Volume: 2013
Issue: default
Year: 2013

New and emerging treatment options for biliary tract cancer

Author(s): Noel MS | Hezel AF
Volume: 2013
Issue: default
Year: 2013

Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma

Author(s): Yuan Z | Tian L | Wang P | Song Y | Dong Y | Zhuang H
Volume: 2013
Issue: default
Year: 2013

Isolated epithelioid trophoblastic tumor of the vagina: a case report and review of the literature

Author(s): Zhao J | Xiang Y | Zhao D | Ren T | Feng F | Wan X
Volume: 2013
Issue: default
Year: 2013

Focus on treatment of lung carcinoid tumor

Author(s): Noel-Savina E | Descourt R
Volume: 2013
Issue: default
Year: 2013

Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Author(s): Chen D | Cheng J | Yang K | Ma Y | Yang F
Volume: 2013
Issue: default
Year: 2013

Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance

Author(s): Sha JJ | Bo JJ | Pan JH | Zhang LH | Xuan HQ | Chen W | Li D | Wang ZL | Liu DM | Huang YR
Volume: 2013
Issue: default
Year: 2013

Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum ß-hCG: a case report and literature review

Author(s): Ji M | Lu Y | Guo L | Feng F | Wan X | Xiang Y
Volume: 2013
Issue: default
Year: 2013

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis

Author(s): Zarogoulidis K | Boutsikou E | Zarogoulidis P | Darwiche K | Freitag L | Porpodis K | Latsios D | Kontakiotis T | Huang H | Li Q | Hohenforst-Schmidt W | Kipourou M | Turner JF | Spyratos D
Volume: 2013
Issue: default
Year: 2013

Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC

Author(s): Wu X | Liang WH | Hou X | Lin Z | Zhao HY | Huang Y | Fang WF | Zhao YY | Wu JX | Yang YP | Xue C | Hu ZH | Zhang J | Zhang JW | Ma YX | Zhou T | Qin T | Zhang L
Volume: 2013
Issue: default
Year: 2013

Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking

Author(s): Tan Q | Wang G | Huang J | Ding ZP | Luo QQ | Mok T | Tao Q | Lu S
Volume: 2013
Issue: default
Year: 2013

Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer

Author(s): Wang Z | Wang Z | Liang Z | Liu J | Shi W | Bai P | Lin X | Magaye R | Zhao J
Volume: 2013
Issue: default
Year: 2013

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody

Author(s): Fushida S | Oyama K | Kinoshita J | Yagi Y | Okamoto K | Tajima H | Ninomiya I | Fujimura T | Ohta T
Volume: 2013
Issue: default
Year: 2013

Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model

Author(s): Kim DY | Song KJ | Kim SU | Yoo EJ | Park JY | Ahn SH | Han KH
Volume: 2013
Issue: default
Year: 2013

Survivin – biology and potential as a therapeutic target in oncology

Author(s): Cheung CHA | Huang CC | Tsai FY | Lee JYC | Cheng SM | Chang YC | Huang YC | Chen SH | Chang JY
Volume: 2013
Issue: default
Year: 2013

The emerging and diverse roles of sirtuins in cancer: a clinical perspective

Author(s): Yuan H | Su L | Chen WY
Volume: 2013
Issue: default
Year: 2013

Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy

Author(s): Xu XX | Yan B | Wang ZX | Yu Y | Wu XX | Zhang YZ
Volume: 2013
Issue: default
Year: 2013

Targeting hedgehog signaling in cancer: research and clinical developments

Author(s): Xie J | Bartels CM | Barton SW | Gu D
Volume: 2013
Issue: default
Year: 2013

Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis

Author(s): Inokawa Y | Nomoto S | Hishida M | Hayashi M | Kanda M | Nishikawa Y | Takeda S | Fujiwara M | Koike M | Sugimoto H | Fujii T | Nakayama G | Yamada S | Tanaka C | Kobayashi D | Kodera Y
Volume: 2013
Issue: default
Year: 2013

Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer

Author(s): Ono M | Ito T | Kanai T | Murayama K | Koyama H | Maeno K | Mochizuki Y | Iesato A | Hanamura T | Okada T | Watanabe T | Ito K
Volume: 2013
Issue: default
Year: 2013

AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines

Author(s): Leal P | Garcia P | Sandoval A | Buchegger K | Weber H | Tapia O | Roa JC
Volume: 2013
Issue: default
Year: 2013

Emerging targets in cancer management: role of the CXCL12/CXCR4 axis

Author(s): Cojoc M | Peitzsch C | Trautmann F | Polishchuk L | Telegeev GD | Dubrovska A
Volume: 2013
Issue: default
Year: 2013

The relationship between Lin28 and the chemotherapy response of gastric cancer

Author(s): Teng RY | Zhou JC | Jiang ZN | Xu CY | Li ZD | Wang QC | Xu CP | Guo JF | Shen JG | Wang LB
Volume: 2013
Issue: default
Year: 2013

Double siRNA-targeting of cIAP2 and LIVIN results in synergetic sensitization of HCT-116 cells to oxaliplatin treatment

Author(s): Bavykin AS | Korotaeva AA | Poyarkov SV | Syrtsev AV | Tjulandin SA | Karpukhin AV
Volume: 2013
Issue: default
Year: 2013

Estimation of the displacement of cardiac substructures and the motion of the coronary arteries using electrocardiographic gating

Author(s): Tan W | Xu L | Wang X | Qiu D | Han G | Hu D
Volume: 2013
Issue: default
Year: 2013

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer

Author(s): Denaro N | Lo Nigro C | Russi EG | Merlano MC
Volume: 2013
Issue: default
Year: 2013

Impact of age on functional exercise correlates in patients with advanced lung cancer

Author(s): Wang LY | Wu HD | Chen KY | Hsieh CH | Lai CC
Volume: 2013
Issue: default
Year: 2013

Resveratrol decreases B-cell lymphoma-2 expression and viability in GH3 pituitary adenoma cells of the rat

Author(s): Voellger B | Kirches E | Wilisch-Neumann A | Weise A | Tapia-Perez JH | Rupa R | Mawrin C | Firsching R
Volume: 2013
Issue: default
Year: 2013

Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients

Author(s): Tejerizo-García A | Jiménez-López JS | Muñoz-González JL | Bartolomé-Sotillos S | Marqueta-Marqués L | López-González G | Pérez-Regadera Gómez JF
Volume: 2013
Issue: default
Year: 2013

IAP proteins as targets for drug development in oncology

Author(s): Dubrez L | Berthelet J | Glorian V
Volume: 2013
Issue: default
Year: 2013

Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells

Author(s): Castellanos JA | Merchant NB | Nagathihalli NS
Volume: 2013
Issue: default
Year: 2013

Targeting cancer stem cells: emerging role of Nanog transcription factor

Author(s): Wang ML | Chiou SH | Wu CW
Volume: 2013
Issue: default
Year: 2013

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition

Author(s): Espinoza I | Pochampally R | Xing F | Watabe K | Miele L
Volume: 2013
Issue: default
Year: 2013

How to detour Treg cells in T cell-based antitumor immune therapy

Author(s): Zheng S | Shen Y | Song Y | Yuan Y
Volume: 2013
Issue: default
Year: 2013

Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus

Author(s): Feng JF | Zhao HG | Liu JS | Chen QX
Volume: 2013
Issue: default
Year: 2013

Combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma

Author(s): Yang R | Xu Y | Li P | Zhang X | Wang J | Gu D | Wang Y
Volume: 2013
Issue: default
Year: 2013

Potential of ponatinib to treat chronic myeloid leukemia and acute lymphoblastic leukemia

Author(s): Price KE | Saleem N | Lee G | Steinberg M
Volume: 2013
Issue: default
Year: 2013

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells

Author(s): Heinrich B | Goepfert K | Delic M | Galle PR | Moehler M
Volume: 2013
Issue: default
Year: 2013

Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli

Author(s): Han JB | Sang F | Chang JJ | Hua YQ | Shi WD | Tang LH | Liu LM
Volume: 2013
Issue: default
Year: 2013

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy

Author(s): Solanki AA | Chang DT | Liauw SL
Volume: 2013
Issue: default
Year: 2013

Combining molecular targeted agents with radiation therapy for malignant gliomas

Author(s): Scaringi C | Enrici RM | Minniti G
Volume: 2013
Issue: default
Year: 2013

Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens

Author(s): Kader YA | El-Nahas T | Sakr A
Volume: 2013
Issue: default
Year: 2013

Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas

Author(s): Kato R | Hasegawa K | Ishii R | Owaki A | Torii Y | Oe S | Hirasawa H | Kobayashi Y | Udagawa Y,
Volume: 2013
Issue: default
Year: 2013

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples

Author(s): Altimari A | de Biase D | De Maglio G | Gruppioni E | Capizzi E | Degiovanni A | D'Errico A | Pession A | Pizzolitto S | Fiorentino M | Tallini G
Volume: 2013
Issue: default
Year: 2013

Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1–6 cells

Author(s): Jeng KS | Sheen IS | Jeng WJ | Yu MC | Hsiau HI | Chang FY | Tsai HH
Volume: 2013
Issue: default
Year: 2013

Single nucleotide polymorphisms in the mitochondrial displacement loop and age at onset of non-Hodgkin lymphoma

Author(s): Fan H | Wang C | Guo Z
Volume: 2013
Issue: default
Year: 2013

Update on oncolytic viral therapy – targeting angiogenesis

Author(s): Tysome JR | Lemoine NR | Wang Y
Volume: 2013
Issue: default
Year: 2013

Critical analysis of the potential for targeting STAT3 in human malignancy

Author(s): Peyser ND | Grandis JR
Volume: 2013
Issue: default
Year: 2013

Update on imatinib for gastrointestinal stromal tumors: duration of treatment

Author(s): Linch M | Claus J | Benson C
Volume: 2013
Issue: default
Year: 2013

Effect of transarterial chemoembolization with miriplatin plus epirubicin on local control of hepatocellular carcinoma: a retrospective comparison with miriplatin monotherapy

Author(s): Hashimoto N | Iwazawa J | Ohue S | Mitani T
Volume: 2013
Issue: default
Year: 2013

The role of fluorescence diagnosis in clinical practice

Author(s): Sieroń A | Sieroń-Stołtny K | Kawczyk-Krupka A | Latos W | Kwiatek S | Straszak D | Bugaj AM
Volume: 2013
Issue: default
Year: 2013

Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells

Author(s): Chen YH | Wang JY | Pan BS | Mu YF | Lai MS | So EC | Wong TS | Huang BM
Volume: 2013
Issue: default
Year: 2013

Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

Author(s): Xu R | Ma N | Wang F | Ma L | Chen R | Chen R | Kebinu M | Ma LL | Han ZC | Ayixiamu | Mayier M | Su PC | Naman YM | Jieensi H | Yang HX | Adili A | Aili S | Liu J
Volume: 2013
Issue: default
Year: 2013

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

Author(s): Diaz-Miqueli A | Saurez Martinez G
Volume: 2013
Issue: default
Year: 2013

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system

Author(s): Rokita M | Stec R | Bodnar L | Charkiewicz R | Korniluk J | Smoter M | Cichowicz M | Chyczewski L | Nikliński J | Kozłowski W | Szczylik C
Volume: 2013
Issue: default
Year: 2013

Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis

Author(s): Yang Z | Wei C | Luo Z | Li L
Volume: 2013
Issue: default
Year: 2013

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer

Author(s): Luo RZ | Yuan ZY | Li M | Xi SY | Fu J | He J
Volume: 2013
Issue: default
Year: 2013

The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective

Author(s): Montanaro L | Treré D | Derenzini M
Volume: 2013
Issue: default
Year: 2013

Comparison of imaging-based gross tumor volume and pathological volume determined by whole-mount serial sections in primary cervical cancer

Author(s): Zhang Y | Hu J | Li J | Wang N | Li W | Zhou Y | Liu J | Wei L | Shi M | Wang S | Wang J | Li X | Ma W
Volume: 2013
Issue: default
Year: 2013

Gamma secretase inhibitors of Notch signaling

Author(s): Olsauskas-Kuprys R | Zlobin Z | Osipo C
Volume: 2013
Issue: default
Year: 2013

Current status of bevacizumab in advanced ovarian cancer

Author(s): Tomao F | Papa A | Rossi L | Caruso D | Benedetti Panici P | Venezia M | Tomao S
Volume: 2013
Issue: default
Year: 2013

Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX

Author(s): Takatori E | Shoji T | Sawai T | Kurose A | Sugiyama T
Volume: 2013
Issue: default
Year: 2013

A miR-SNP of the XPO5 gene is associated with advanced non-small-cell lung cancer

Author(s): Ding C | Li C | Wang H | Li B | Guo Z
Volume: 2013
Issue: default
Year: 2013

Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors

Author(s): Li ZY | Zhang XH | Chen Y | Guo JG | Sai K | Yang QY | Chen ZP | Mou YG
Volume: 2013
Issue: default
Year: 2013

Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer

Author(s): Huang Y | He Y | Ye S | Li X | Zhong Q | Chen Z | Jin X
Volume: 2013
Issue: default
Year: 2013

Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract

Author(s): Nagashima Y | Maeda N | Yamamoto S | Yoshino S | Oka M
Volume: 2013
Issue: default
Year: 2013

Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer

Author(s): Maric G | Rose AA | Annis MG | Siegel PM
Volume: 2013
Issue: default
Year: 2013

MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma

Author(s): Tang M | Lin L | Cai H | Tang J | Zhou Z
Volume: 2013
Issue: default
Year: 2013

Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology

Author(s): González-Masiá JA | García-Olmo D | García-Olmo DC
Volume: 2013
Issue: default
Year: 2013

Clinical significance of the thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase mRNA expressions in hepatocellular carcinoma patients receiving 5-fluorouracil-based transarterial chemoembolization treatment

Author(s): Zhao H | Zhao Y | Guo Y | Huang Y | Lin S | Xue C | Xu F | Zhang Y | Zhao L | Hu Z | Zhang L
Volume: 2013
Issue: default
Year: 2013

Drugs for solid cancer the productivity crisis prompts a rethink

Author(s): Rosel D | Brabek J | Vesely P | Fernandes M
Volume: 2013
Issue: default
Year: 2013

Apoptosis and G2/M arrest induced by Allium ursinum (ramson) watery extract in an AGS gastric cancer cell line

Author(s): Xu XY | Song GQ | Yu YQ | Ma HY | Ma L | Jin YN
Volume: 2013
Issue: default
Year: 2013

Potential use of custirsen to treat prostate cancer

Author(s): Higano CS
Volume: 2013
Issue: default
Year: 2013

Efficacy of intraarterial chemoinfusion therapy for locally advanced breast cancer patients: a retrospective analysis of 28 cases

Author(s): Zhang W | Liu R | Wang YY | Qian S | Wang JH | Yan ZP | Zhang HW
Volume: 2013
Issue: default
Year: 2013

Long term results of sentinel lymph node biopsy in early oral squamous cell carcinoma

Author(s): Dequanter D | Shahla M | Paulus P | Lothaire P
Volume: 2013
Issue: default
Year: 2013

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation

Author(s): Abdel Kader Y | Le Chevalier T | El-Nahas T | Sakr A
Volume: 2013
Issue: default
Year: 2013

Malignant thrombosis of the superior vena cava caused by non-small-cell lung cancer treated with radiation and erlotinib: a case with complete and prolonged response over 3 years

Author(s): Wang JY | Liang J | Wang WQ | Ouyang H | Wang LH
Volume: 2013
Issue: default
Year: 2013

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

Author(s): Yoo EJ | Shin HS | Kim SU | Joo DJ | Park JY | Choi GH | Kim DY | Ahn SH | Seong J | Koh MJ | Han KH | Chon CY
Volume: 2013
Issue: default
Year: 2013

Cyclin D1 affects epithelial–mesenchymal transition in epithelial ovarian cancer stem cell-like cells

Author(s): Jiao J | Huang L | Ye F | Shi MF | Cheng XD | Wang XY | Hu DX | Xie X | Lu WG
Volume: 2013
Issue: default
Year: 2013

Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia

Author(s): Cross M | Bach E | Tran T | Krahl R | Jaekel N | Niederwieser D | Junghanss C | Maschmeyer G | Al-Ali HK
Volume: 2013
Issue: default
Year: 2013

Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors

Author(s): Zhang Z | Hao C | Wang L | Liu P | Zhao L | Zhu C | Tian X
Volume: 2013
Issue: default
Year: 2013

Preliminary study of CT in combination with MRI perfusion imaging to assess hemodynamic changes during angiogenesis in a rabbit model of lung cancer

Author(s): Zhang Q | Shi B | Liu Z | Zhang M | Zhang W
Volume: 2013
Issue: default
Year: 2013

Primary primitive neuroectodermal tumor of the cervix

Author(s): Li B | Ouyang L | Han X | Zhou Y | Tong X | Zhang S | Zhang Q
Volume: 2013
Issue: default
Year: 2013

Aberrant DNA methylation of ESR1 and p14ARF genes could be useful as prognostic indicators in osteosarcoma

Author(s): Sonaglio V | de Carvalho AC | Toledo SRC | Salinas-Souza C | Carvalho AL | Petrilli AS | de Camargo B | Vettore AL
Volume: 2013
Issue: default
Year: 2013

Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients

Author(s): Liu J | Shi L | Sartor O | Culbertson R
Volume: 2013
Issue: default
Year: 2013

Human epidermal growth factor receptor 2-positive breast cancer: which cytotoxic agent best complements trastuzumab's efficacy in vitro?

Author(s): Hurrell T | Outhoff K
Volume: 2013
Issue: default
Year: 2013

Fatal bleeding in a nasopharyngeal carcinoma patient after concurrent chemoradiation plus cetuximab: a case report

Author(s): Zheng LY | Yan SX | Yan DF | Yang JS | Wang YX
Volume: 2013
Issue: default
Year: 2013

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors

Author(s): Cho DC
Volume: 2013
Issue: default
Year: 2013

Current treatment options for management of anal intraepithelial neoplasia

Author(s): Weis SE
Volume: 2013
Issue: default
Year: 2013

Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer

Author(s): Chen ZW | Luo QQ | Jian H | Zhou Z | Cheng BJ | Lu S | Liao ML
Volume: 2013
Issue: default
Year: 2013

Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma

Author(s): Özün Özbay P | Ekinci T | Yiğit S | Yavuzcan A | Uysal S | Soylu F | Cakalogaoglu F
Volume: 2013
Issue: default
Year: 2013

Current management options for recurrent adrenocortical carcinoma

Author(s): Glover AR | Ip JCY | Zhao JT | Soon PSH | Robinson BG | Sidhu SB
Volume: 2013
Issue: default
Year: 2013

Increased CD70 expression is associated with clinical resistance to cisplatin-based chemotherapy and poor survival in advanced ovarian carcinomas

Author(s): Liu N | Sheng X | Liu Y | Zhang X | Yu J
Volume: 2013
Issue: default
Year: 2013

Nanomaterials in the application of tumor vaccines: advantages and disadvantages

Author(s): Li XD | Gao JY | Yang Y | Fang HY | Han YJ | Wang XM | Ge W
Volume: 2013
Issue: default
Year: 2013

Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today

Author(s): Kallianos A | Tsimpoukis S | Zarogoulidis P | Darwiche K | Charpidou A | Tsioulis I | Trakada G | Porpodis K | Spyratos D | Panoutspoulos A | Veletza L | Kostopoulos K | Kostopoulos C | Karapantzos I | Tsakiridis K | Hohenforst-Schmidt W | Zarogoulidis K | Rapti A | Syrigos K
Volume: 2013
Issue: default
Year: 2013

The different radiosensitivity when combining erlotinib with radiation at different administration schedules might be related to activity variations in c-MET-PI3K-AKT signal transduction

Author(s): Zhuang HQ | Bo QF | Yuan ZY | Wang J | Zhao LJ | Wang P
Volume: 2013
Issue: default
Year: 2013

 Telangiectatic osteosarcoma: a review of literature

Author(s): Liu J | Liu S | Wang J | Zhu W | Hua Y | Sun W | Cai Z
Volume: 2013
Issue: default
Year: 2013

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

Author(s): Shi Y | Qin R | Wang ZK | Dai GH
Volume: 2013
Issue: default
Year: 2013

Abundance of Flt3 and its ligand in astrocytic tumors

Author(s): Eßbach C | Andrae N | Pachow D | Warnke JP | Wilisch-Neumann A | Kirches E | Mawrin C
Volume: 2013
Issue: default
Year: 2013

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma

Author(s): Luo J | Chen M | Huang H | Yan T | Zhang M | Zhang K | Deng S
Volume: 2013
Issue: default
Year: 2013

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer

Author(s): Berardi R | Santoni M | Morgese F | Ballatore Z | Savini A | Onofri A | Mazzanti P | Pistelli M | Pierantoni C | De Lisa M | Caramanti M | Pagliaretta S | Pellei C | Cascinu S
Volume: 2013
Issue: default
Year: 2013

Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation

Author(s): Zhuang XB | Qiao TK | Yuan SJ | Chen W | Zha L | Yan L
Volume: 2013
Issue: default
Year: 2013

New dilemmas in small-cell lung cancer TNM clinical staging

Author(s): Zarogoulidis K | Latsios D | Porpodis K | Zarogoulidis P | Darwiche K | Antoniou N | Hohenforst-Schmidt W | Eleftheriadou E | Boutsikou E | Kontakiotis T
Volume: 2013
Issue: default
Year: 2013

Interleukin-12 prevents colorectal cancer liver metastases in mice

Author(s): Shen F | Li JL | Cai WS | Zhu GH | Gu WL | Jia L | Xu B
Volume: 2013
Issue: default
Year: 2013

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma

Author(s): Terpos E | Kanellias N | Christoulas D | Kastritis E | Dimopoulos MA
Volume: 2013
Issue: default
Year: 2013

Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination

Author(s): Yu L | Jing Y | Ma S | Li F | Zhang YF
Volume: 2013
Issue: default
Year: 2013

Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer

Author(s): Chen XH | Li ZQ | Peng H | Jin SM | Fu HQ | Zhu TC | Weng XG
Volume: 2013
Issue: default
Year: 2013

Treatment outcome of advanced pancreatic cancer patients who are ineligible for a clinical trial

Author(s): Ueda A | Hosokawa A | Ogawa K | Yoshita H | Ando T | Kajiura S | Fujinami H | Kawai K | Nishikawa J | Tajiri K | Minemura M | Sugiyama T
Volume: 2013
Issue: default
Year: 2013

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma

Author(s): Zhang L | Shi L | Zhao X | Wang Y | Yue W
Volume: 2013
Issue: default
Year: 2013

Antitumor effects and mechanisms of dendritic cells stimulated by sCD40L on ovarian cancer cells in vitro

Author(s): Zhang ZM | Yang XM | Zhang C | Zhang MJ | Li X | Zhang FH | Kang S | Wang SJ | Shan BE
Volume: 2013
Issue: default
Year: 2013

Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer

Author(s): Wu Q | Shi Y | Chen L | Xiao XY | Dai GH
Volume: 2013
Issue: default
Year: 2013

Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors

Author(s): L'Heureux-Lebeau B | Saliba I
Volume: 2013
Issue: default
Year: 2013

A review of the use of somatostatin analogs in oncology

Author(s): Keskin O | Yalcin S
Volume: 2013
Issue: default
Year: 2013

Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment

Author(s): Rachmut IH | Samuels N | Melnick SJ | Ramachandran C | Sharabi Y | Pavlovsky A | Maimon Y | Shoham J
Volume: 2013
Issue: default
Year: 2013

Candidate cancer-targeting agents identified by expression-profiling arrays

Author(s): Termglinchan V | Wanichnopparat W | Suwanwongse K | Teeyapant C | Chatpermporn K | Leerunyakul K | Chuadpia K | Sirimaneethum O | Wijitworawong P | Mutirangura W | Aporntewan C | Vinayanuwattikun C | Mutirangura A
Volume: 2013
Issue: default
Year: 2013

Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment

Author(s): Tian DW | Sun Y | Yang Y | Lei MD | Ding N | Han RF
Volume: 2013
Issue: default
Year: 2013

Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma

Author(s): Hirte HW
Volume: 2013
Issue: default
Year: 2013

RUNX3 gene promoter demethylation by 5-Aza-CdR induces apoptosis in breast cancer MCF-7 cell line

Author(s): Kang HF | Dai ZJ | Bai HP | Lu WF | Ma XB | Bao X | Lin S | Wang XJ
Volume: 2013
Issue: default
Year: 2013

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer

Author(s): Rick FG | Block NL | Schally AV
Volume: 2013
Issue: default
Year: 2013

Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)

Author(s): Amini A | Ehteda A | Masoumi Moghaddam S | Akhter J | Pillai K | Morris DL
Volume: 2013
Issue: default
Year: 2013

Bevacizumab in high-grade gliomas: a review of its uses, toxicity assessment, and future treatment challenges

Author(s): Rahmathulla G | Hovey EJ | Hashemi-Sadraei N | Ahluwalia MS
Volume: 2013
Issue: default
Year: 2013

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study

Author(s): Huang L | Li GM | Zhu JY | Li Z | Li T | Leng XS
Volume: 2013
Issue: default
Year: 2013

A brief review of different types of sweat-gland carcinomas in the eyelid and orbit

Author(s): Zhang L | Ge S | Fan X
Volume: 2013
Issue: default
Year: 2013

Evaluation of the efficacy of a novel radical neck dissection preserving the external jugular vein, greater auricular nerve, and deep branches of the cervical nerve

Author(s): Li Y | Zhang J | Yang K
Volume: 2013
Issue: default
Year: 2013

Laparoscopic partial nephrectomy of thyroid cancer metastasis: case report and review of the literature

Author(s): Cochetti G, Puxeddu E, Del Zingaro M, D’Amico F, Cottini E, Barillaro F, Mearini E
Volume: 2013
Issue: default
Year: 2013

MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B

Author(s): Yu XY | Zhang Z | Liu J | Zhan B | Kong CZ
Volume: 2013
Issue: default
Year: 2013

HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients

Author(s): Qin T | Yuan Z | Peng R | Bai B | Shi Y | Teng X | Liu D | Wang S
Volume: 2013
Issue: default
Year: 2013

A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging

Author(s): Yokoyama J | Fujimaki M | Ohba S | Anzai A | Yoshii R | Ito S | Kojima M | Ikeda K
Volume: 2013
Issue: default
Year: 2013

Update of research on the role of EZH2 in cancer progression

Author(s): Shen L | Cui J | Liang S | Pang Y | Liu P
Volume: 2013
Issue: default
Year: 2013

Primary malignant fibrous histiocytoma of the breast: report of one case

Author(s): Liu C | Zhao Z | Zhang Q | Wu Y | Jin F
Volume: 2013
Issue: default
Year: 2013

Application of quantum dots as vectors in targeted survivin gene siRNA delivery

Author(s): Zhao JJ | Qiu XL | Wang ZP | Pan J | Chen J | Han JS
Volume: 2013
Issue: default
Year: 2013

Resting-state magnetoencephalography study of “small world” characteristics and cognitive dysfunction in patients with glioma

Author(s): Hu X | Lei T | Xu HZ | Zou YJ | Liu HY
Volume: 2013
Issue: default
Year: 2013

Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer

Author(s): Dong X | Yang M | Sun H | Lü J | Zheng Z | Li Z | Zhong L
Volume: 2013
Issue: default
Year: 2013

Systematic review of dasatinib in chronic myeloid leukemia

Author(s): Breccia M | Salaroli A | Molica M | Alimena G
Volume: 2013
Issue: default
Year: 2013

Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experience

Author(s): Boselli C | Renzi C | Gemini A | Castellani E | Trastulli S | Desiderio J | Corsi A | Barberini F | Cirocchi R | Santoro A | Parisi A | Redler A | Noya G
Volume: 2013
Issue: default
Year: 2013

Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature

Author(s): Xu D | Bi T | Lan H | Yu W | Wang W | Cao F | Jin K
Volume: 2013
Issue: default
Year: 2013

Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential

Author(s): Alexanian A | Sorokin A
Volume: 2013
Issue: default
Year: 2013

Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer

Author(s): Gao Y | Gao F | Liu Z | Song LP
Volume: 2013
Issue: default
Year: 2013

Improving survival and preventing recurrence of diffuse large B-cell lymphoma in younger patients: current strategies and future directions

Author(s): Karlin L | Coiffier B
Volume: 2013
Issue: default
Year: 2013

Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma

Author(s): Wang Z | Zhang H | He L | Dong W | Li J | Shan Z | Teng W
Volume: 2013
Issue: default
Year: 2013

Antitumor effects of inductive hyperthermia using magnetic ferucarbotran nanoparticles on human lung cancer xenografts in nude mice

Author(s): Araya T | Kasahara K | Nishikawa S | Kimura H | Sone T | Nagae H | Ikehata Y | Nagano I | Fujimura M
Volume: 2013
Issue: default
Year: 2013

Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression

Author(s): Gu X | Xu Z | Zhu LY | Wang L | Li K | Pei Q
Volume: 2013
Issue: default
Year: 2013

Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management

Author(s): Ho AS | Turcan S | Chan TA
Volume: 2013
Issue: default
Year: 2013

Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib

Author(s): Rajendra R | Jones RL | Pollack SM
Volume: 2013
Issue: default
Year: 2013

Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma

Author(s): Wang D | Yang JX | Cao DY | Wan XR | Feng FZ | Huang HF | Shen K | Xiang Y
Volume: 2013
Issue: default
Year: 2013

Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation

Author(s): Duan Y | Zhao X | Ren W | Wang X | Yu KF | Li D | Zhang X | Zhang Q
Volume: 2013
Issue: default
Year: 2013

Novel Bruton's tyrosine kinase inhibitors currently in development

Author(s): D'Cruz OJ | Uckun FM
Volume: 2013
Issue: default
Year: 2013

Docetaxel for non small cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

Author(s): Yamane H | Ochi N | Yasugi M | Tabayashi T | Yamagishi T | Monobe Y | Hisamoto A | Kiura K | Takigawa N
Volume: 2013
Issue: default
Year: 2013

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

Author(s): Nelson V | Ziehr J | Agulnik M | Johnson M
Volume: 2013
Issue: default
Year: 2013

Profile of bosutinib and its clinical potential in the treatment of chronic myeloid leukemia

Author(s): Keller-von Amsberg G | Koschmieder S
Volume: 2013
Issue: default
Year: 2013

Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview

Author(s): Zhu C | Jin K
Volume: 2013
Issue: default
Year: 2013

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer

Author(s): Boutsikou E | Kontakiotis T | Zarogoulidis P | Darwiche K | Eleptheriadou E | Porpodis K | Galaktidou G | Sakkas L | Hohenforst-Schmidt W | Tsakiridis K | Karaiskos T | Zarogoulidis K
Volume: 2013
Issue: default
Year: 2013

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options

Author(s): Elit L | Hirte H
Volume: 2013
Issue: default
Year: 2013

Molecular guided therapy for advanced pancreatic cancer patients with PI3K activated mutation: vision or illusion?

Author(s): Gazzah A | Gonzales DB | Levy A | Bahleda R | Ducreux M | Lacroix L | Soria JC
Volume: 2013
Issue: default
Year: 2013

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Author(s): Hamizi S | Freyer G | Bakrin N | Henin E | Mohtaram A | Le Saux O | Falandry C
Volume: 2013
Issue: default
Year: 2013

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer

Author(s): Geva R | Vecchione L | Tejpar S | Piessevaux H | Van Cutsem E | Prenen H
Volume: 2013
Issue: default
Year: 2013

Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients – a preliminary result

Author(s): Hsieh CH | Tien HJ | Hsiao SM | Wei MC | Wu WY | Sun HD | Wang LY | Hsieh YP | Chen YJ | Shueng PW
Volume: 2013
Issue: default
Year: 2013

The feasibility of a fiber optic laser approach to relieving lymphedematous syndrome: a case report

Author(s): Palmieri B | Di Cerbo A | Rottigni V | Fistetto G | Iannitti T
Volume: 2013
Issue: default
Year: 2013

Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma

Author(s): Wei LC | Wang N | Shi M | Liu JY | Li JP | Zhang Y | Huang YH | Li X | Chen Y
Volume: 2013
Issue: default
Year: 2013

Arsenic trioxide-mediated oxidative stress and genotoxicity in human hepatocellular carcinoma cells

Author(s): Alarifi S | Ali D | Alkahtani S | Siddiqui MA | Ali BA
Volume: 2013
Issue: default
Year: 2013

Pseudomembranous colitis within radiotherapy field following concurrent chemoradiation therapy: a case report

Author(s): Shen BJ | Lin SC | Shueng PW | Chou YH | Tseng LM | Hsieh CH
Volume: 2013
Issue: default
Year: 2013

Learning curve for endoscopic thyroidectomy: a single teaching hospital study

Author(s): Cao F | Jin K | Cui B | Xie B
Volume: 2013
Issue: default
Year: 2013

Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model

Author(s): Zhao NB | Tang H | Yang K | Chen D
Volume: 2013
Issue: default
Year: 2013

Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responses

Author(s): Andoh Y | Makino N | Yamakawa M
Volume: 2013
Issue: default
Year: 2013

Expression of novel tumor markers of pancreatic adenocarcinomas in intrahepatic cholangiocarcinomas

Author(s): Zong M | Jia L | Li L
Volume: 2013
Issue: default
Year: 2013

Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: patient considerations, novel opportunities, and future directions

Author(s): Bedoya DJ | Mitsiades N
Volume: 2013
Issue: default
Year: 2013

Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer

Author(s): Hart CD | De Boer RH
Volume: 2013
Issue: default
Year: 2013

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study

Author(s): Huang L | Li GM | Zhu JY | Li Z | Li T | Leng XS
Volume: 2012
Issue: default
Year: 2012

Endoscopy-verified occult subependymal dissemination of glioblastoma and brain metastasis undetected by MRI: prognostic significance

Author(s): Iacoangeli M | Di Rienzo A | Colasanti R | Zizzi A | Gladi M | Alvaro L | Nocchi N | Di Somma LG | Scarpelli M | Scerrati M
Volume: 2012
Issue: default
Year: 2012

Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions

Author(s): Karanikas M | Machairiotis N | Zarogoulidis P | Stylianaki A | Courcoutsakis N | Mitrakas A | Touzopoulos P | Lyratzopoulos N | Kouklakis G | Spanoudakis M | Polychronidis A
Volume: 2012
Issue: default
Year: 2012

Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

Author(s): Xu F | Wu J | Xue C | Zhao Y | Jiang W | Lin L | Wu X | Lu Y | Bai H | Xu J | Zhu G | Zhang L
Volume: 2012
Issue: default
Year: 2012

Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells

Author(s): Chen W | Liu XQ | Qiao TK | Yuan SJ
Volume: 2012
Issue: default
Year: 2012

Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma

Author(s): Cangemi G | Reggiardo G | Barco S | Barbagallo L | Conte M | D'Angelo P | Bianchi M | Favre C | Galleni B | Melioli G | Haupt R | Garaventa A | Corrias MV
Volume: 2012
Issue: default
Year: 2012

Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma

Author(s): Chen R | Yang K | Zhao NB | Zhao D | Chen D | Zhao CR | Tang H
Volume: 2012
Issue: default
Year: 2012

β-blockers: a novel class of antitumor agents

Author(s): Ji Y | Chen S | Xiao X | Zheng S | Li K
Volume: 2012
Issue: default
Year: 2012

Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

Author(s): Fernandes I | Pacheco TR | Costa A | Santos AC | Fernandes AR | Santos M | Oliveira AG | Casimiro S | Quintela A | Fernandes A | Ramos M | Costa L
Volume: 2012
Issue: default
Year: 2012

Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas

Author(s): Iacoangeli M | Di Rienzo A | Colasanti R | Alvaro L | Nocchi N | Polonara G | Di Somma LG | Zizzi A | Scarpelli M | Scerrati M
Volume: 2012
Issue: default
Year: 2012

The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis

Author(s): Tasci C | Ozkaya S | Ozkara B | Tozkoparan E | Ozkan M | Karadurmus N | Serdar M | Balkan A | Bilgic H
Volume: 2012
Issue: default
Year: 2012

Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma

Author(s): Hountis P | Foukas PG | Matthaios D | Kefala M | Chelis L | Pantelidaki A | Panayiotides IG | Karakitsos P | Kakolyris S
Volume: 2012
Issue: default
Year: 2012

Cancer stem cells in head and neck cancer

Author(s): Allegra E | Trapasso S
Volume: 2012
Issue: default
Year: 2012

The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institution

Author(s): Zhang J | Huang Y | Li X | Guo Y | Zhao Y | Xue C | Hu Z | Zhang L | Zhao H
Volume: 2012
Issue: default
Year: 2012

Tumor necrosis factor signaling is implicated in intestinal mucosal injury of cancer cachexic mice

Author(s): Jia Y | Tian W | Cui B
Volume: 2012
Issue: default
Year: 2012

A study of mifepristone/IFN-γ-induced apoptosis of human cholangiocarcinoma cell line FRH-0201 in vitro

Author(s): Sun QL | Zhang XG | Xing QT | Ding P | Feng JB | Wu XP | Wang ZM
Volume: 2012
Issue: default
Year: 2012

Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance

Author(s): Chen HF | Wu TQ | Li ZY | Shen HS | Tang JQ | Fu WJ | Yuan ZG | Hou J
Volume: 2012
Issue: default
Year: 2012

Targeted treatments for cervical cancer: a review

Author(s): Peralta-Zaragoza O | Bermúdez-Morales VH | Pérez-Plasencia C | Salazar-León J | Gómez-Cerón C | Madrid-Marina V
Volume: 2012
Issue: default
Year: 2012

γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer

Author(s): Matthaios D | Foukas PG | Kefala M | Hountis P | Trypsianis G | Panayiotides IG | Chatzaki E | Pantelidaki E | Bouros D | Karakitsos P | Kakolyris S
Volume: 2012
Issue: default
Year: 2012

Current and emerging treatment options for nasopharyngeal carcinoma

Author(s): Spratt DE | Lee N
Volume: 2012
Issue: default
Year: 2012

Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901

Author(s): Dan L | Jian D | Na L | Xiaozhong W
Volume: 2012
Issue: default
Year: 2012

Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology

Author(s): Sherrill B | Kaye JA | Sandin R | Cappelleri JC | Chen C
Volume: 2012
Issue: default
Year: 2012

Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells

Author(s): Li Y | Dai C | Li J | Wang W | Song G
Volume: 2012
Issue: default
Year: 2012

Research progress on criteria for discontinuation of EGFR inhibitor therapy

Author(s): Zhuang HQ | Yuan ZY | Wang J | Wang P | Zhao LJ | Zhang BL
Volume: 2012
Issue: default
Year: 2012

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma

Author(s): Yao X | Wang X | Wang Z | Dai L | Zhang G | Yan Q | Zhou W
Volume: 2012
Issue: default
Year: 2012

Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma

Author(s): Hsieh CH | Shueng PW | Hsiao SM | Wei MC | Wu WY | Sun HD | Tien HJ | Wang LY | Hsieh YP
Volume: 2012
Issue: default
Year: 2012

Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma

Author(s): Fostier K | De Becker A | Schots R
Volume: 2012
Issue: default
Year: 2012

Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival

Author(s): Zarogoulidis P | Mavroudi M | Porpodis K | Domvri K | Sakkas A | Machairiotis N | Stylianaki A | Tsiotsios A | Courcoutsakis N | Zarogoulidis K
Volume: 2012
Issue: default
Year: 2012

Denosumab: a new option in the treatment of bone metastases from urological cancers

Author(s): Yuasa T | Yamamoto S | Urakami S | Fukui I | Yonese J
Volume: 2012
Issue: default
Year: 2012

Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia

Author(s): Bai J | Guo A | Hong Z | Kuai W
Volume: 2012
Issue: default
Year: 2012

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer

Author(s): Zoratto F | Rossi L | Zullo A | Papa A | Zaccarelli E | Tomao L | Giordani E | Colonna M | Baiano G | Tomao S
Volume: 2012
Issue: default
Year: 2012

Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial

Author(s): Yamamoto D | Iwase S | Tsubota Y | Sueoka N | Yamamoto C | Kitamura K | Odagiri H | Nagumo Y
Volume: 2012
Issue: default
Year: 2012

Evaluation of therapeutic effect of tumor-targeted therapy

Author(s): Li XF | Li MD | Shen H | Fang XF | Huang PT | Yuan Y
Volume: 2012
Issue: default
Year: 2012

Emerging treatment options for patients with recurrent advanced thymic epithelial tumors

Author(s): Evans TL
Volume: 2012
Issue: default
Year: 2012

Expression of transient receptor potential channel 6 in cervical cancer

Author(s): Wan Q | Zheng A | Liu XJ | Chen YL | Han L
Volume: 2012
Issue: default
Year: 2012

The role of EGFR-targeting strategies in the treatment of head and neck cancer

Author(s): Dequanter D | Shahla M | Paulus P | Lothaire PH
Volume: 2012
Issue: default
Year: 2012

Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects

Author(s): Shodeinde AL | Barton BE
Volume: 2012
Issue: default
Year: 2012

Targeted therapy for esophagogastric cancers: a review

Author(s): Khattak MA | Martin HL | Karapetis CS
Volume: 2012
Issue: default
Year: 2012

Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment

Author(s): Pham PV | Vu NB | Duong TT | Nguyen TT | Truong NH | Phan NLC | Vuong TG | Pham VQ | Nguyen HM | Nguyen KT | Nguyen NT | Nguyen KG | Khat LT | Le DV | Truong KD | Phan NK
Volume: 2012
Issue: default
Year: 2012

Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand

Author(s): Jia XY | Yu Q | Zhang ZH | Yang XF
Volume: 2012
Issue: default
Year: 2012

Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects

Author(s): Sato A
Volume: 2012
Issue: default
Year: 2012

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)

Author(s): He K | Cui B | Li G | Wang H | Jin K | Teng L
Volume: 2012
Issue: default
Year: 2012

Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus

Author(s): Cen P | Amato RJ
Volume: 2012
Issue: default
Year: 2012

Downregulation of CD44 reduces doxorubicin resistance of CD44+CD24- breast cancer cells

Author(s): Phuc PV | Nhan PLC | Nhung TH | Tam NT | Hoang NM | Tue VG | Thuy DT | Ngoc PK
Volume: 2011
Issue: default
Year: 2011

Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments

Author(s): Gupta SG | Carballido ES | Fishman M
Volume: 2011
Issue: default
Year: 2011

Current therapeutic strategies for invasive and metastatic bladder cancer

Author(s): Vishnu P | Mathew J | Tan WW
Volume: 2011
Issue: default
Year: 2011

The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine

Author(s): Ahmad EI | Gawish HH | Al Azizi NMA | Elhefni AM
Volume: 2011
Issue: default
Year: 2011

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval

Author(s): Yamamoto Y | Kawano I | Iwase H
Volume: 2011
Issue: default
Year: 2011

Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents

Author(s): Khan MK | Khan N | Almasan A | Macklis R
Volume: 2011
Issue: default
Year: 2011

Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia

Author(s): Hoeksema KA | Jayanthan A | Cooper T | Gore L | Trippett T | Boklan J | Arceci RJ | Narendran A
Volume: 2011
Issue: default
Year: 2011

Targeted treatment for chronic lymphocytic leukemia

Author(s): Masood A | Sher T | Paulus A | Miller KC | Chitta KS | Chanan-Khan A
Volume: 2011
Issue: default
Year: 2011

Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies

Author(s): Kobayakawa M | Kojima Y
Volume: 2011
Issue: default
Year: 2011

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

Author(s): Muñoz-Couselo E | Pérez-García J | Cortés J
Volume: 2011
Issue: default
Year: 2011

Surgical management of retrorectal tumors: a retrospective study of a 9-year experience in a single institution

Author(s): Lin CZ | Jin KT | Lan HR | Teng LS | Lin JJ | Chen WB
Volume: 2011
Issue: default
Year: 2011

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer

Author(s): Deshpande H | Marler V | Sosa JA
Volume: 2011
Issue: default
Year: 2011

Targeted agents for the treatment of metastatic melanoma

Author(s): Monzon JG | Dancey J
Volume: 2012
Issue: default
Year: 2012

Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine

Author(s): Sun W | Modak S
Volume: 2012
Issue: default
Year: 2012

Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation

Author(s): Jacob NK | Cooley JV | Shirai K | Chakravarti A
Volume: 2012
Issue: default
Year: 2012

Application of reticulated platelets to transfusion management during autologous stem cell transplantation

Author(s): Parco S | Vascotto F
Volume: 2012
Issue: default
Year: 2012

Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC

Author(s): Ballas MS | Chachoua A
Volume: 2011
Issue: default
Year: 2011

Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets

Author(s): Kounnis V | Ioachim E | Svoboda M | Tzakos A | Sainis I | Thalhammer T | Steiner G | Briasoulis E
Volume: 2011
Issue: default
Year: 2011

Bendamustine in the treatment of non-Hodgkin’s lymphomas

Author(s): Fredrick Hagemeister | George Manoukian
Volume: 2009
Issue: default
Year: 2009

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma

Author(s): Khaldoun Almhanna | Philip A Philip
Volume: 2009
Issue: default
Year: 2009

Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

Author(s): Francesco Perri | Francesco Longo | Franco Ionna | et al
Volume: 2009
Issue: default
Year: 2009

Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia

Author(s): Kelly M Reilly | David F Kisor
Volume: 2009
Issue: default
Year: 2009

Gemcitabine for the treatment of advanced nonsmall cell lung cancer

Author(s): Luca Toschi | Federico Cappuzzo
Volume: 2009
Issue: default
Year: 2009

Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer

Author(s): Francesco Di Costanzo | Silvia Gasperoni | Virginia Rotella | Federica Di Costanzo
Volume: 2009
Issue: default
Year: 2009

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Author(s): Kerry J Williams | A Craig Lockhart
Volume: 2009
Issue: default
Year: 2009

Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)

Author(s): John T Vetto
Volume: 2009
Issue: default
Year: 2009

Multiple roles and therapeutic implications of Akt signaling in cancer

Author(s): Emiliano Calvo | Victoria Bolós | Enrique Grande
Volume: 2009
Issue: default
Year: 2009

Targeted therapy in the treatment of malignant gliomas

Author(s): Rimas V Lukas | Adrienne Boire | M Kelly Nicholas
Volume: 2009
Issue: default
Year: 2009

Role of trabectedin in the treatment of soft tissue sarcoma

Author(s): Alexandre Christinat | Serge Leyvraz
Volume: 2009
Issue: default
Year: 2009

The evolving role of zoledronic acid in early breast cancer

Author(s): Michael Gnant
Volume: 2009
Issue: default
Year: 2009

Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib

Author(s): Charles Chuah | Junia V Melo
Volume: 2009
Issue: default
Year: 2009

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab

Author(s): Giuseppe Tonini | Alice Calvieri | Bruno Vincenzi | Daniele Santini
Volume: 2009
Issue: default
Year: 2009

Targeting cancers in the gastrointestinal tract: role of capecitabine

Author(s): Muhammad Wasif Saif
Volume: 2009
Issue: default
Year: 2009

Targeted treatment of chronic myeloid leukemia: role of imatinib

Author(s): Ila Tamascar | Jeyanthi Ramanarayanan
Volume: 2009
Issue: default
Year: 2009

Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management

Author(s): Ann Gramza | Kathryn G Schuff
Volume: 2008
Issue: default
Year: 2009

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients

Author(s): Per Pfeiffer | Camilla Qvortrup | Jon K Bjerregaard
Volume: 2009
Issue: default
Year: 2008

Topotecan in the treatment of relapsed small cell lung cancer

Author(s): Elisabeth Quoix
Volume: 2008
Issue: default
Year: 2008

Targeted therapies in the management of colorectal carcinoma: role of bevacizumab

Author(s): Ajithkumar Puthillath | Anush Patel | Marwan G Fakih
Volume: 2009
Issue: default
Year: 2008

Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling

Author(s): Wessen Maruwge | Pádraig D’Arcy | Annika Folin | Slavica Brnjic | Johan Wejde | et al
Volume: 2008
Issue: default
Year: 2008

Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL)

Author(s): Xavier Troussard | Edouard Cornet | Jean-François Lesesve | Carine Kourel | Hossein Mossafa
Volume: 2008
Issue: default
Year: 2008

Relationship between arachidonic acid pathway and human renal cell carcinoma

Author(s): Masahide Matsuyama | Rikio Yoshimura
Volume: 2008
Issue: default
Year: 2008

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer

Author(s): Thomas Powles | Siobhan McFaul | Justin Stebbing | Peter Wilson | Tim Oliver et al
Volume: 2008
Issue: default
Year: 2008

Temozolomide in malignant glioma

Author(s): Gregor Dresemann
Volume: 2010
Issue: default
Year: 2010

Current and emerging therapies for the treatment of pancreatic cancer

Author(s): Rebecca A Moss | Clifton Lee
Volume: 2010
Issue: default
Year: 2010

Dynamic changes to survivin subcellular localization are initiated by DNA damage

Author(s): Maritess Gay Asumen | Tochukwu V Ifeacho | Luke Cockerham | et al
Volume: 2010
Issue: default
Year: 2010

Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma

Author(s): Nousheen Samad | Anas Younes
Volume: 2010
Issue: default
Year: 2010

Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study

Author(s): William C Dooley | John P Thropay | Gary J Schreiber | et al
Volume: 2010
Issue: default
Year: 2010

Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics

Author(s): Kimbach Tran Carpiuc | Gianantonio Rosti | Fausto Castagnetti | et al
Volume: 2010
Issue: default
Year: 2010

Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial

Author(s): Peter D Beitsch | Rakesh R Patel | John D Lorenzetti | et al
Volume: 2010
Issue: default
Year: 2010

Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells

Author(s): Borhane Annabi | Eric Vaillancourt-Jean | Alexander G Weil | et al
Volume: 2010
Issue: default
Year: 2010

Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis

Author(s): William C Dooley | James C Wurzer | Mohamed Megahy | et al
Volume: 2011
Issue: default
Year: 2011

Survivin-T34A: molecular mechanism and therapeutic potential

Author(s): Jonathan R Aspe | Nathan R Wall
Volume: 2010
Issue: default
Year: 2010

New developments in the treatment of metastatic gastric cancer: focus on trastuzumab

Author(s): Rose JS | Bekaii-Saab TS
Volume: 2011
Issue: default
Year: 2011

Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma

Author(s): Michael J Burdick | Roger M Macklis
Volume: 2009
Issue: default
Year: 2009

Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma

Author(s): Martina Lehnert | Heinz Ludwig | Niklas Zojer
Volume: 2009
Issue: default
Year: 2009

Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma

Author(s): Anita Schwandt1 | Laura S Wood1 | Brian Rini1,2 | Robert Dreicer1,2
Volume: 2009
Issue: default
Year: 2009

Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib

Author(s): Massimo Breccia | Giuliana Alimena
Volume: 2008
Issue: default
Year: 2008

CTLA-4 blockade: therapeutic potential in cancer treatments

Author(s): Ahmad A Tarhini | Fatima Iqbal
Volume: 2010
Issue: default
Year: 2010

Anti-angiogenesis therapies: their potential in cancer management

Author(s): Andrew Eichholz | Shairoz Merchant | Andrew M Gaya
Volume: 2010
Issue: default
Year: 2010

A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency

Author(s): Mariam Hammadi | Jacques-Olivier Pers | Christian Berthou | et al
Volume: 2010
Issue: default
Year: 2010

The dual kinase complex FAK-Src as a promising therapeutic target in cancer

Author(s): Victoria Bolós | Joan Manuel Gasent | Sara López-Tarruella | et al
Volume: 2010
Issue: default
Year: 2010

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

Author(s): Steven E McCormack | Erica D Warlick
Volume: 2010
Issue: default
Year: 2010

The bevacizumab experience in advanced renal cell carcinoma

Author(s): Lauren C Harshman | Sandy Srinivas
Volume: 2010
Issue: default
Year: 2010

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

Author(s): Carmen Criscitiello | Debora Fumagalli | Kamal S Saini | et al
Volume: 2011
Issue: default
Year: 2010

Antioxidant oils and Salmonella enterica Typhimurium reduce tumor in an experimental model of hepatic metastasis

Author(s): Sorenson BS | Banton KL | Augustin LB | Leonard AS | Saltzman DA
Volume: 2011
Issue: default
Year: 2011

An update on TroVax® for the treatment of progressive castration-resistant prostate cancer

Author(s): Abern M | Kaufman HL | Latchamsetty K
Volume: 2011
Issue: default
Year: 2011

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer

Author(s): Charu Aggarwal | Hossein Borghaei
Volume: 2009
Issue: default
Year: 2009